Florida Attorney General James Uthmeier filed a lawsuit against Eli Lilly, Novo Nordisk, Sanofi and three pharmacy benefit managers, accusing them of participating in a pricing scheme that drove up insulin costs. The complaint, filed in Miami-Dade County Circuit Court,…

The FDA has issued a warning letter to Houston-based Empower Pharmacy after an inspection found evidence that certain compounded drugs failed to meet conditions for exemptions under federal law. The agency said Empower compounded products that appeared to be essentially…

The cell and gene therapy pipeline is no longer a distant possibility. It is arriving now, and health systems have a narrowing window to prepare. With more than 35 Food and Drug Administration-approved Cell and Gene Therapies (CGT) and a…

An FDA advisory panel will meet Sept. 23 to review GRAIL’s Galleri test, a blood-based screening tool for multiple cancer types that would be the first FDA-authorized multi-cancer early detection device if approved, according to the agency’s executive summary released…

U.S. News & World Report released its pediatric Honor Roll Sept. 15, naming 11 children’s hospitals as the nation’s best. Here are the leaders overseeing pharmacy at each. Ann & Robert H. Lurie Children’s Hospital of Chicago: Jenny Elhadary, PharmD,…

Outdated and unsaleable medications account for an estimated 1.5% of the nearly $700 billion annual U.S. pharmacy market, or approximately $10 billion in potentially recoverable revenue for pharmacies, according to a Sept. 21 Health Affairs Forefront commentary. Here are five…

China and India together account for 90% of new active pharmaceutical ingredient drug master files submitted for U.S. medicines in 2025, as the U.S. share continues to shrink, according to a Sept. 11 analysis from U.S. Pharmacopeia’s Medicine Supply Map.…

Novo Nordisk unveiled its 2030 strategic targets at a Capital Markets Day in London Sept. 21, aiming to reassure investors it can navigate looming patent expirations for semaglutide, the active ingredient in Ozempic and Wegovy, according to a Sept. 21…

Pfizer agreed to give HHS a portion of its increased revenue if it is able to charge higher drug prices abroad, according to a “most favored nation” contract released Sept. 19, Bloomberg reported.  The contract, released by consumer watchdog Public…

President Donald Trump said he would be “demanding” drugmakers further split up vaccines into five doses given at six-month intervals, claiming the change would cause “a massive reduction in autism,” according to a Sept. 18 report by The Washington Post.…